Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia

Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Austr...

Full description

Saved in:
Bibliographic Details
Main Authors: L. de Abreu, Kara L. Holloway, Mark A. Kotowicz, Julie A. Pasco
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2015/373762
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562563364159488
author L. de Abreu
Kara L. Holloway
Mark A. Kotowicz
Julie A. Pasco
author_facet L. de Abreu
Kara L. Holloway
Mark A. Kotowicz
Julie A. Pasco
author_sort L. de Abreu
collection DOAJ
description Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Australian women. Methods. This study included 1167 women, aged 20–94 years, enrolled in the Geelong Osteoporosis Study. Multivariable logistic regression was used to identify predictors for progression to diabetes or regression to normoglycaemia (from IFG), over 10 years of follow-up. Results. At baseline the proportion of women with IFG was 33.8% and 6.5% had diabetes. Those with fasting dysglycaemia had higher obesity-related factors, lower serum HDL cholesterol, and lower physical activity. Over a decade, the incidence of progression from IFG to diabetes was 18.1 per 1,000 person-years (95% CI, 10.7–28.2). Fasting plasma glucose and serum triglycerides were important factors in both progression to diabetes and regression to normoglycaemia. Conclusions. Our results show a transitional process; those with IFG had risk factors intermediate to normoglycaemics and those with diabetes. This investigation may help target interventions to those with IFG at high risk of progression to diabetes and thereby prevent cases of diabetes.
format Article
id doaj-art-caf09136cdf14b4098bbe9f69948986f
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-caf09136cdf14b4098bbe9f69948986f2025-02-03T01:22:19ZengWileyJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/373762373762Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or NormoglycaemiaL. de Abreu0Kara L. Holloway1Mark A. Kotowicz2Julie A. Pasco3School of Medicine, Deakin University, 285 Ryrie Street, Geelong, VIC 3220, AustraliaSchool of Medicine, Deakin University, 285 Ryrie Street, Geelong, VIC 3220, AustraliaSchool of Medicine, Deakin University, 285 Ryrie Street, Geelong, VIC 3220, AustraliaSchool of Medicine, Deakin University, 285 Ryrie Street, Geelong, VIC 3220, AustraliaAims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Australian women. Methods. This study included 1167 women, aged 20–94 years, enrolled in the Geelong Osteoporosis Study. Multivariable logistic regression was used to identify predictors for progression to diabetes or regression to normoglycaemia (from IFG), over 10 years of follow-up. Results. At baseline the proportion of women with IFG was 33.8% and 6.5% had diabetes. Those with fasting dysglycaemia had higher obesity-related factors, lower serum HDL cholesterol, and lower physical activity. Over a decade, the incidence of progression from IFG to diabetes was 18.1 per 1,000 person-years (95% CI, 10.7–28.2). Fasting plasma glucose and serum triglycerides were important factors in both progression to diabetes and regression to normoglycaemia. Conclusions. Our results show a transitional process; those with IFG had risk factors intermediate to normoglycaemics and those with diabetes. This investigation may help target interventions to those with IFG at high risk of progression to diabetes and thereby prevent cases of diabetes.http://dx.doi.org/10.1155/2015/373762
spellingShingle L. de Abreu
Kara L. Holloway
Mark A. Kotowicz
Julie A. Pasco
Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
Journal of Diabetes Research
title Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_full Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_fullStr Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_full_unstemmed Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_short Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
title_sort dysglycaemia and other predictors for progression or regression from impaired fasting glucose to diabetes or normoglycaemia
url http://dx.doi.org/10.1155/2015/373762
work_keys_str_mv AT ldeabreu dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia
AT karalholloway dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia
AT markakotowicz dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia
AT julieapasco dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia